Samuel J. Reich - May 20, 2022 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Signature
/s/ Samuel J. Reich
Stock symbol
SABS
Transactions as of
May 20, 2022
Transactions value $
$0
Form type
4
Date filed
5/23/2022, 05:45 PM
Previous filing
Mar 18, 2022
Next filing
Sep 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Other $0 -2.5M -82.03% $0.00 548K May 20, 2022 Via Big Cypress Holdings LLC F1
transaction SABS Common Stock Other $0 +207K +20700.1% $0.00 208K May 20, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
F2 The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.